Data / Form D filings / Tasca Therapeutics Corp
Tasca Therapeutics Corp: Form D filings
Tasca Therapeutics Corp, a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on December 1, 2025, reports $48.1 million sold of a $70.2 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 55 SPINELLI PLACE, Cambridge, MA, 02138
- Phone
- (617) 390-4306
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2046762
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Amendment | $70,199,981 | $48,099,985 | $22,099,996 | 9 | Nov 13, 2024 | sec.gov |
| Nov 29, 2024 | New notice | $70,199,981 | $24,149,994 | $46,049,987 | 7 | Nov 13, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Praveen Tipirneni | Director | |
| David Fallace | Director | |
| Seth Lieblich | Director | |
| Michael Aberman | Director | |
| Drew King | Executive Officer | |
| Milenko Cicmil | Executive Officer, Director | |
| Xu Wu | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 1, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tasca Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.